Changes in cultured endothelial cell glycosaminoglycans under hyperglycemic conditions and the effect of insulin and heparin

Cardiovascular Diabetology

Volumn 8, Issue , 2009, Pages 46-

  Han, Juying ^a   Zhang, Fuming ^b   Xie, Jin ^b   Linhardt, Robert J ^b   Hiebert, Linda M ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAZOLE DERIVATIVE; GLUCOSE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; INSULIN;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ARTERY ENDOTHELIUM; ARTICLE; CARBOHYDRATE ANALYSIS; CELL LEVEL; CELL PROTECTION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ENDOTHELIUM CELL; HYPERGLYCEMIA; NONHUMAN; SWINE;

ANIMALS; CELLS, CULTURED; DRUG INTERACTIONS; ELECTROPHORESIS, AGAR GEL; ENDOTHELIAL CELLS; GLUCOSE; GLYCOSAMINOGLYCANS; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HEPARITIN SULFATE; INSULIN; SUS SCROFA; SWINE; SYNDECANS; TIME FACTORS;

EID: 70350118012     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-8-46     Document Type: Article

References (44)

1. Kjellen L, Lindahl U. Proteoglycans: Structures and Interactions. Annu Rev Biochem 1991, 60:443-475. 10.1146/annurev.bi.60.070191.002303, 1883201.
2. Linhardt RJ, Toida T. Carbohydrates As Drugs. 1997, 277-341.
3. Bernfield M, Kokenyesi R, Kato M, Hinkes MT, Spring J, Gallo RL, Lose EJ. Biology of the Syndecans: a Family of Transmembrane Heparan Sulfate Proteoglycans. Annu Rev Cell Biol 1992, 8:365-393. 10.1146/annurev.cb.08.110192.002053, 1335744.
4. Salmivirta M, Jalkanen M. Syndecan Family of Cell Surface Proteoglycans: Developmentally Regulated Receptors for Extracellular Effector Molecules. Experientia 1995, 51:863-872. 10.1007/BF01921737, 7556568.
5. Vlodavsky I, Bar-Shavit R, Korner G, Fuks Z. Extracellular Matrix Bound Growth Factors, Enzymes and Plasma Proteins. 1993, 327-343.
6. Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L. Heparan Sulfate Proteoglycans of the Cardiovascular System. Specific Structures Emerge but How Is Synthesis Regulated?. J Clin Invest 1997, 100:S67-S75.
7. Iozzo RV, Cohen I. Altered Proteoglycan Gene Expression and the Tumor Stroma. Experientia 1993, 49:447-455. 10.1007/BF01923588, 8500599.
8. Jackson DG. Human Leucocyte Heparan Sulphate Proteoglycans and Their Roles in Inflammation. Biochem Soc Trans 1997, 25:220-224.
9. Woude FJ, van Det NF. Heparan Sulphate Proteoglycans and Diabetic Nephropathy. Exp Nephrol 1997, 5:180-188.
10. Vernier RL, Klein DJ, Sisson SP, Mahan JD, Oegema TR, Brown DM. Heparan Sulfate - Rich Anionic Sites in the Human Glomerular Basement Membrane. Decreased Concentration in Congenital Nephrotic Syndrome. N Engl J Med 1983, 309:1001-1009.
11. Hoven MJ, Rops AL, Bakker MA, Aten J, Rutjes N, Roestenberg P, Goldschmeding R, Zcharia E, Vlodavsky I, vand V, Berden JH. Increased Expression of Heparanase in Overt Diabetic Nephropathy. Kidney Int 2006, 70:2100-2108.
12. Gambaro G, Cavazzana AO, Luzi P, Piccoli A, Borsatti A, Crepaldi G, Marchi E, Venturini AP, Baggio B. Glycosaminoglycans Prevent Morphological Renal Alterations and Albuminuria in Diabetic Rats. Kidney Int 1992, 42:285-291. 10.1038/ki.1992.288, 1328749.
13. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria Reflects Widespread Vascular Damage. The Steno Hypothesis. Diabetologia 1989, 32:219-226. 10.1007/BF00285287, 2668076.
14. Wasty F, Alavi MZ, Moore S. Distribution of Glycosaminoglycans in the Intima of Human Aortas: Changes in Atherosclerosis and Diabetes Mellitus. Diabetologia 1993, 36:316-322. 10.1007/BF00400234, 8477876.
15. Brown DM, Klein DJ, Michael AF, Oegema TR. 35S-Glycosaminoglycan and 35S-Glycopeptide Metabolism by Diabetic Glomeruli and Aorta. Diabetes 1982, 31:418-425. 10.2337/diabetes.31.5.418, 7152134.
16. Kjellen L, Bielefeld D, Hook M. Reduced Sulfation of Liver Heparan Sulfate in Experimentally Diabetic Rats. Diabetes 1983, 32:337-342. 10.2337/diabetes.32.4.337, 6219905.
17. Levy P, Picard J, Bruel A. Evidence for Diabetes-Induced Alterations in the Sulfation of Heparin Sulfate Intestinal Epithelial Cells. Life Sci 1984, 35:2613-2620. 10.1016/0024-3205(84)90029-8, 6239964.
18. Han J, Woytowich AE, Mandal AK, Hiebert LM. Heparanase Upregulation in High Glucose-Treated Endothelial Cells Is Prevented by Insulin and Heparin. Exp Biol Med (Maywood) 2007, 232:927-934.
19. Katz A, Van Dijk DJ, Aingorn H, Erman A, Davies M, Darmon D, Hurvitz H, Vlodavsky I. Involvement of Human Heparanase in the Pathogenesis of Diabetic Nephropathy. Isr Med Assoc J 2002, 4:996-1002.
20. Han J, Mandal AK, Hiebert LM. Endothelial Cell Injury by High Glucose and Heparanase Is Prevented by Insulin, Heparin and Basic Fibroblast Growth Factor. Cardiovasc Diabetol 2005, 4:1475-2840.
21. Gotlieb AI, Spector W. Migration into an in Vitro Experimental Wound: a Comparison of Porcine Aortic Endothelial and Smooth Muscle Cells and the Effect of Culture Irradiation. Am J Pathol 1981, 103:271-282. 1903820, 7195151.
22. Jaques LB, Wice SM, Hiebert LM. Determination of Absolute Amounts of Heparin and of Dextran Sulfate in Plasma in Microgram Quantities. J Lab Clin Med 1990, 115:422-432.
23. Kaji T, Yamada A, Miyajima S, Yamamoto C, Fujiwara Y, Wight TN, Kinsella MG. Cell Density-Dependent Regulation of Proteoglycan Synthesis by Transforming Growth Factor-Beta(1) in Cultured Bovine Aortic Endothelial Cells. J Biol Chem 2000, 275:1463-1470. 10.1074/jbc.275.2.1463, 10625699.
24. Gharagozlian S, Borrebaek J, Henriksen T, Omsland TK, Shegarfi H, Kolset SO. Effect of Hyperglycemic Condition on Proteoglycan Secretion in Cultured Human Endothelial Cells. Eur J Nutr 2006, 45:369-375. 10.1007/s00394-006-0608-9, 16810465.
25. Vogl-Willis CA, Edwards IJ. High Glucose-Induced Alterations in Subendothelial Matrix Perlecan Leads to Increased Monocyte Binding. Arterioscler Thromb Vasc Biol 2004, 24:858-863. 10.1161/01.ATV.0000126375.60073.74, 15031130.
26. Vogl-Willis CA, Edwards IJ. High-Glucose-Induced Structural Changes in the Heparan Sulfate Proteoglycan, Perlecan, of Cultured Human Aortic Endothelial Cells. Biochim Biophys Acta 2004, 1672:36-45.
27. Nugent MA, Iozzo RV. Fibroblast Growth Factor-2. Int J Biochem Cell Biol 2000, 32:115-120. 10.1016/S1357-2725(99)00123-5, 10687947.
28. Richardson JV, Wright CB, Hiratzka LF. The Role of Endothelium in the Patency of Small Venous Substitutes. J Surg Res 1980, 28:556-562. 10.1016/0022-4804(80)90048-7, 6448319.
29. Colwell JA, Lopes-Virella MF. A Review of the Development of Large-Vessel Disease in Diabetes Mellitus. Am J Med 1988, 85:113-118. 10.1016/0002-9343(88)90403-2, 3057888.
30. Tamsma JT, van den BJ, Bruijn JA, Assmann KJ, Weening JJ, Berden JH, Wieslander J, Schrama E, Hermans J, Veerkamp JH. Expression of Glomerular Extracellular Matrix Components in Human Diabetic Nephropathy: Decrease of Heparan Sulphate in the Glomerular Basement Membrane. Diabetologia 1994, 37:313-320. 10.1007/BF00398060, 8174847.
31. Ishihara M, Fedarko NS, Conrad HE. Involvement of Phosphatidylinositol and Insulin in the Coordinate Regulation of Proteoheparan Sulfate Metabolism and Hepatocyte Growth. J Biol Chem 1987, 262:4708-4716.
32. Reizes O, Goldberger O, Smith AC, Xu Z, Bernfield M, Bickel PE. Insulin Promotes Shedding of Syndecan Ectodomains From 3T3-L1 Adipocytes: a Proposed Mechanism for Stabilization of Extracellular Lipoprotein Lipase. Biochemistry 2006, 45:5703-5711. 10.1021/bi052263h, 16669614.
33. Hsueh WA, Law RE. Insulin Signaling in the Arterial Wall. Am J Cardiol 1999, 84:21J-24J. 10.1016/S0002-9149(99)00353-7, 10418854.
34. Mather K, Anderson TJ, Verma S. Insulin Action in the Vasculature: Physiology and Pathophysiology. J Vasc Res 2001, 38:415-422. 10.1159/000051074, 11561143.
35. Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, Quon MJ. Roles for Insulin Receptor, PI3-Kinase, and Akt in Insulin-Signaling Pathways Related to Production of Nitric Oxide in Human Vascular Endothelial Cells. Circulation 2000, 101:1539-1545.
36. Olgemoller B, Schwaabe S, Gerbitz KD, Schleicher ED. Elevated Glucose Decreases the Content of a Basement Membrane Associated Heparan Sulphate Proteoglycan in Proliferating Cultured Porcine Mesangial Cells. Diabetologia 1992, 35:183-186. 10.1007/BF00402553, 1547925.
37. Kasinath BS. Effect of Insulin on High-Glucose Medium-Induced Changes in Rat Glomerular Epithelial Cell Metabolism of Glycoconjugates. Arch Biochem Biophys 1995, 318:286-294. 10.1006/abbi.1995.1232, 7733656.
38. Unger E, Kjellen L, Eriksson UJ. Effect of Insulin on the Altered Production of Proteoglycans in Rib Cartilage of Experimentally Diabetic Rats. Arch Biochem Biophys 1991, 285:205-210. 10.1016/0003-9861(91)90350-R, 1897927.
39. Rohrbach DH, Wagner CW, Star VL, Martin GR, Brown KS, Yoon JW. Reduced Synthesis of Basement Membrane Heparan Sulfate Proteoglycan in Streptozotocin-Induced Diabetic Mice. J Biol Chem 1983, 258:11672-11677.
40. Mandal AK, Puchalski JT, Lemley-Gillespie S, Taylor CA, Kohno M. Effect of Insulin and Heparin on Glucose-Induced Vascular Damage in Cell Culture. Kidney Int 2000, 57:2492-2501. 10.1046/j.1523-1755.2000.00108.x, 10844618.
41. Mandal AK, Lyden TW, Fazel A, Saklayen MG, Mehrotra B, Mehling B, Taylor CA, Yokokawa K, Colvin RV. Heparin-Induced Endothelial Cell Cytoskeletal Reorganization: a Potential Mechanism for Vascular Relaxation. Kidney Int 1995, 48:1508-1516. 10.1038/ki.1995.441, 8544408.
42. Yokokawa K, Kohno M, Mandal AK, Tahara H, Yanagisawa M, Takeda T, Kohne M. Heparin Suppresses Endothelin-1 Peptide and MRNA Expression in Cultured Endothelial Cells of Spontaneously Hypertensive Rats. J Am Soc Nephrol 1994, 4:1683-1689.
43. Nader HB, Buonassisi V, Colburn P, Dietrich CP. Heparin Stimulates the Synthesis and Modifies the Sulfation Pattern of Heparan Sulfate Proteoglycan From Endothelial Cells. J Cell Physiol 1989, 140:305-310. 10.1002/jcp.1041400216, 2745565.
44. Nader HB, Toma L, Pinhal MA, Buonassisi V, Colburn P, Dietrich CP. Effect of Heparin and Dextran Sulfate on the Synthesis and Structure of Heparan Sulfate From Cultured Endothelial Cells. Semin Thromb Hemost 1991, 17(Suppl 1):47-56.